Philip John Berger

Philip John Berger

Auto-generated profile, based on publicly available information

Philip John Berger

Ritchie Centre for Baby Health Research, Monash Institute of Medical Research, Monash University, Victoria, Australia

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2009 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
SSScott A. Sands
Scott A. Sands
BEBradley Edwards
Bradley Edwards
VKVanessa J. Kelly
Vanessa J. Kelly
MDMalcolm R. Davidson
Malcolm R. Davidson
MWMalcolm H. Wilkinson
Malcolm H. Wilkinson
PBPhilip J. Berger
Philip J. Berger
Rapid arterial O2 desaturation during apnea in the preterm infant has obvious clinical implications but to date no adequate explanation for why it exists. Understanding the factors influencing the rate of arterial O2 desaturation during apnea ( ) is complicated by the non-linear O2 dissociation curve, falling pulmonary O2 uptake, and by the fact that O2 desaturation is biphasic, exhibiting a rapid phase (stage 1) followed by a slower phase when severe desaturation develops (stage 2). Using a mathematical model incorporating pulmonary uptake dynamics, we found that elevated metabolic O2 consumption accelerates throughout the entire desaturation process. By contrast, the remaining factors have a restricted temporal influence: low pre-apneic alveolar causes an early onset of desaturation, but thereafter has little impact; reduced lung volume, hemoglobin content or cardiac output, accelerates during stage 1, and finally, total blood O2 capacity (blood volume and hemoglobin content) alone determines during stage 2. Preterm infants with elevated metabolic rate, respiratory depression, low lung volume, impaired cardiac reserve, anemia, or hypovolemia, are at risk for rapid and profound apneic hypoxemia. Our insights provide a basic physiological framework that may guide clinical interpretation and design of interventions for preventing sudden apneic hypoxemia. When breathing stops, the flow of O2 into and the flow of CO2 out of the body cease. Such an event, termed an apnea, can be especially dangerous in preterm infants in whom it can lead to a rapid decline in arterial O2 saturation, reaching rates of 3–8% per second, rapidly reducing O2 to a level that could lead to neurological damage. Despite extensive experimental research, we have a poor mechanistic understanding of the causes of rapidly developing hypoxemia. We describe a new mathematical model that allows examination of the importance of the major cardiorespiratory factors that are likely to influence the speed at which arterial hypoxemia worsens during apnea. We found that high metabolic rate as well as reduced pre-apneic ventilation, lung volume, cardiac output, hemoglobin content, blood O2 affinity, and blood volume accelerate the development of hypoxemia during apnea. Importantly, the cardiorespiratory factors that contribute to rapid hypoxemia are all pertinent to the preterm infant during early postnatal development. Thus the newborn is highly susceptible to rapid and severe desaturation, potentially explaining the propensity of preterm infants, particularly those with apnea, to neurological impairment.

1 September 2001 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
RPRiccardo E. Pfister
Riccardo E. Pfister
CRC. Andrew Ramsden
C. Andrew Ramsden
HNHeather L. Neil
Heather L. Neil
MKMary A. Kyriakides
Mary A. Kyriakides
PBPhilip J. Berger
Philip J. Berger

7 June 2010 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
SSScott A. Sands
Scott A. Sands
BEBradley Edwards
Bradley Edwards
VKVanessa J. Kelly
Vanessa J. Kelly
MDMalcolm R. Davidson
Malcolm R. Davidson
MWMalcolm H. Wilkinson
Malcolm H. Wilkinson
PBPhilip J. Berger
Philip J. Berger

1 June 2005 in Journal of Applied Physiology
Verified
Journal Article
Open access
PDF file
PBPhilip J. Berger
Philip J. Berger
ESElizabeth M. Skuza
Elizabeth M. Skuza
CRC. Andrew Ramsden
C. Andrew Ramsden
MWMalcolm H. Wilkinson
Malcolm H. Wilkinson
We measured the velocity and attenuation of audible sound in the isolated lung of the near-term fetal sheep to test the hypothesis that the acoustic properties of the lung provide a measure of the volume of gas it contains. We introduced pseudorandom noise (bandwidth 70 Hz–7 kHz) to one side of the lung and recorded the noise transmitted to the surface immediately opposite, starting with the lung containing only fetal lung liquid and making measurements after stepwise inflation with air until a leak developed. The velocity of sound in the lung fell rapidly from 187 ± 28.2 to 87 ± 3.7 m/s as lung density fell from 0.93 ± 0.01 to 0.75 ± 0.01 g/ml (lung density = lung weight/gas volume plus lung tissue volume). For technical reasons, no estimate of velocity could be made before the first air injection. Thereafter, as lung density fell to 0.35 ± 0.01 g/ml, there was a further decline in velocity to 69.6 ± 4.6 m/s. High-frequency sound was attenuated as lung density decreased from 1.0 to 0.5 g/ml, with little change thereafter down to a density of 0.35 ± 0.01 g/ml. We conclude that both the velocity of audible sound through the lung and the degree to which high-frequency sound is attenuated in the lung provide information on the degree of inflation of the isolated fetal lung, particularly at high lung densities. If studies of sound transmission through the lung in the intact organism were to confirm these findings, the acoustic properties of the lung could provide a means for monitoring lung aeration during mechanical ventilation of newborn infants.

1 June 2000 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
PBPhilip John Berger
Philip John Berger
ESElizabeth Michalina Skuza
Elizabeth Michalina Skuza
VBVojta Brodecky
Vojta Brodecky
SCSusan Margaret Cranage
Susan Margaret Cranage
TAThomas Michael Adamson
Thomas Michael Adamson
MWMalcolm Howard Wilkinson
Malcolm Howard Wilkinson
High inspired oxygen concentrations have recently been recommended to control Cheyne-Stokes respiration in adults, with the intention of averting periodic apnea and its attendant arterial desaturation. We report a case study on an infant presenting with recurrent apnea and cyanosis in which oxygen treatment led to a gross form of respiratory instability we call episodic breathing, in which a breathing phase of 60 to 90 s alternated with an apnea lasting up to 60 s. When oxygen was discontinued, a profound arterial desaturation developed before breathing recommenced and restored oxygen levels. We propose that episodic breathing is an unusual respiratory pattern that involves the central chemoreceptors and results from the ventilatory threshold (the central Pco2 at which breathing starts) lying considerably above the apneic threshold (the central Pco2at which breathing stops). This feature predisposes to lengthy periods of hyperpnea alternating with lengthy periods of apnea. We suggest that when the case infant returned to air during episodic breathing, termination of apnea was entirely dependent upon carotid body activity, which reached a sufficient level to restart breathing only when arterial desaturation was severe. We conclude that oxygen therapy involves potential risks when employed to treat respiratory disorders involving unstable breathing patterns in the infant.

17 October 2002 in Nature
Verified
Journal Article
Closed access
PDF file
PBPhilip J. Berger
Philip J. Berger
ESElizabeth M. Skuza
Elizabeth M. Skuza
VBVojta Brodecky
Vojta Brodecky
MWMalcolm H. Wilkinson
Malcolm H. Wilkinson